The $1 Billion Bet on Pre-Symptomatic Medicine: Who Will Own the Longitudinal Baseline?
Dr. Dereck Mush, MD, MBALongevity
Healthspan science, diagnostics and the clinics and companies turning ageing into a measurable, treatable target.
Dr. Dereck Mush, MD, MBA
Epigenetic clocks can now show a number moving. That is not the same as proof of slower aging
Dr. Dereck Mush, MD, MBAThe HealthTech Signal
GLP-1 drugs are excellent at losing weight. The muscle question is where healthspan gets decided
GLP-1 drugs are excellent at losing weight. The muscle question is where healthspan gets decided
Dr. Dereck Mush, MD, MBAThe HealthTech Signal
Full body MRI is the fastest growing product in longevity medicine. The evidence has not caught up
Full body MRI is the fastest growing product in longevity medicine. The evidence has not caught up
Dr. Dereck Mush, MD, MBA
